The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vlasov P.N.

Clinical hospital of emergency medicine of Krasnoyarsk named after N.S. Krapovich

Geyze A.V.

Clinical hospital of emergency medicine of Krasnoyarsk named after N.S. Krapovich

Clinical case of joint usage of inotropic and vasodilating drugs in acute decompensated heart failure

Authors:

Vlasov P.N., Geyze A.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2017;10(1): 34‑38

DOI: 10.17116/kardio2017101234-38

Views: 686

Downloaded: 18

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Vlasov PN, Geyze AV. Clinical case of joint usage of inotropic and vasodilating drugs in acute decompensated heart failure. Russian Journal of Cardiology and Cardiovascular Surgery. 2017;10(1):34‑38. (In Russ.)
https://doi.org/10.17116/kardio2017101234-38

 
МСФ на ЯМ
Close metadata
Recommended articles:
In-hospital diuretic resi­stance as a risk factor for poor long-term prognosis in chro­nic heart failure. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):532-539
Remote dielectric sensing to opti­mize therapy for acute deco­mpensation of heart failure. Russian Cardiology Bulletin. 2024;(3):71-80

Keywords:

acute decompensated heart failure
inotropic and vasodilating drugs

Authors:

Vlasov P.N.

Clinical hospital of emergency medicine of Krasnoyarsk named after N.S. Krapovich

Geyze A.V.

Clinical hospital of emergency medicine of Krasnoyarsk named after N.S. Krapovich

List of references:

  1. National Guidelines of OSSN, RCS, RSMST for the diagnosis and treatment of chronic heart failure (4th edition). Heart failure J. 2013;7(81):1-93.
  2. Arutyunov AG, Dragunov DO, Arutyunov GP, Rylova AK, Pashkevich DD, Viter KV. on behalf of the study group. First Open Study of Syndrome of Acute Decompensation of Heart Failure and Concomitant Diseases in Russian Federation: Independent Registry ORAKUL. Cardiology. 2015;5:12-21.
  3. Ponikowski P, Voors AA, Anker SD, Bueno H, John GF, Cleland JGF, Andrew JS, Coats AJS, Falk V. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure/ Eur Heart J. 2016;37(27):2129-2200. doi:10.1093/eurheartj/ehw128
  4. Pavlikova EP, Alexandria LG, Meray IA. Inotropic therapy of acute heart failure: perspective of usage for new calcium sensitizer-levosimendan. Clinical pharmacology and therapy. 2005;14(3):79-84.
  5. Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE. Eur J Heart Fail. 2009;11(3):304-311. doi:10.1093/eurjhf/hfn045
  6. Dschietzig T, Bartsch C, Richter C, Laule M, Baumann G, Stangl K. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB. Circ Res. 2003;92(1):32-40.
  7. McGuane JT, Debrah JE, Sautina L, Jarajapu YP, Novak J, Rubin JP, Grant MB, Segal M, Conrad KP. Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide. Endocrinology. 2011;152(7):2786-2796. doi:10.1210/en.2010-1126
  8. Sarwar M, Samuel CS, Bathgate RA, Stewart DR, Summers RJ. Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins. Br J Pharmacol. 2015;172(4):1005-1019. doi:10.1111/bph.12964
  9. Ponikowski P, Mitrovic V, Ruda M, Fernandez A, Voors AA, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Metra M, et al. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart J. 2014;35:431-441. doi:10.1093/eurheartj/eht459
  10. Teerlink JR, Cotter G, Davison BA, Felder GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KFJr, Dorobantuet MI, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet. 2013;381:29-39. doi:10.1016/S0140-6736(12)61855-8
  11. Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KFJr, Dorobantu MI, Grinfeld M. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. JACC. 2013;61:196-206. doi. org/10.1016/j.jacc.2012.11.005
  12. Zhirov IV, Nasonova SN, Tereshchenko SN, Uskach TM. Clinical case of usage of serelaxin in the patient with acute decompensated heart failure. Russ J Cardiol. 2016;4:83-88.
  13. Kobalava ZD, Villevalde SV, Solov'jova AE, Merai IA. Organoprotective effects of serelaxin in patients with severe decompensated heart failure. Ration Pharmacother Cardiol. 2016;12(4):414-423. doi:org/10.20996/1819-6446-2016-12-4-414-423
  14. Kovaleva GV, Sutygina TYu, Koroleva LYu, Mironov NN. Case report of post-MI reccurrent left ventricular failure management with Serelaxin-recombinant human relaxin-2 (Reasanz, «Novartis»). Cardiology and cardio-vascular surgery. 2015;5:92-94.
  15. Nieminen MS, Fruhwald S, Heunks LM, Suominen PK, Gordon AC, Kivikko M, Pollesello P. Levosimendan: current data, clinical use and future development. Heart Lung Vessel. 2013;5(4):227-245.
  16. Fomin IV, Khomkhoeva MS. Resistance to diuretics: causes, mechanisms, approach to coping. Pharmateca. 2010;12:19-23.
  17. Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. The role of the kidney in heart failure. Eur Heart J. 2012;33(17):2135-2142. doi:10.1093/eurheartj/ehs205
  18. Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KFJr. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007t;9(10):1064-1069.
  19. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009;113(1):12-19. doi:10.1159/000164149
  20. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SN, Bellomo B, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Euro Heart J. 2010;31:703-711. doi:10.1093/eurheartj/ehp507
  21. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International supplements. 2012 March;2:Issue 1. www.kidney-international.org
  22. Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ. Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol. 2010;7:48-58.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.